How Medicare Blocks Access to Lifesaving Treatments

Medicare is expected to soon decide whether to end its Coverage with Evidence Development restriction on TAVR.

The policy has limited access to a standard, less-invasive treatment for severe aortic stenosis in older adults.

Doctors and advocates say lifting the restriction could expand timely care and improve outcomes for millions of seniors.